[ Price : $8.95]
CDER approves 50 novel products in 2024, five less than the 55 products approved in 2023 and well above the 10-year rolling annual...[ Price : $8.95]
FDA approves Array BioPharmas Braftovi to treat some patients with metastatic colorectal cancer with a specific mutation.[ Price : $8.95]
FDA says Alcon recalled one lot of Systane Ultra PF eye drops due to potential fungal contamination.[ Price : $8.95]
FDA approves Galdermas Nemluvio to treat some dermatitis patients aged 12 and older.[ Price : $8.95]
FDA warns Greeces Rontis Hellas about Quality System and Medical Device Reporting violations in its production of a balloon cathet...[ Price : $8.95]
FDA approves Bristol Myers Squibbs Opdivo Qvantig subcutaneous injection for several cancer indications.[ Price : $8.95]
FDA approves Novo Nordisks Alhemo as a prophylaxis for some hemophilia patients.[ Price : $8.95]
FDA approves a new indication for Lillys Zepbound to treat some obese patients with obstructive sleep apnea.